Professional Documents
Culture Documents
Abbott is excited to announce the availability of four new ARCHITECT and ALINITY Clinical Chemistry assays. As part of
our commitment to excellence in Clinical Chemistry, we will be launching more than 20 next-generation assays over the
next two years. Abbott’s investment in new Clinical Chemistry assays and ConCC will optimize your laboratory’s
productivity and build sustained operational excellence by delivering:
• Minimized frequency of cartridge changes with greater onboard stability and optimized kit configurations
• Reduced calibration frequency with longer calibration stability
• Simplified workflows with a single-level calibrator
This letter outlines the group of four ARCHITECT and four ALINITY assays:
Abbott’s next-generation Clinical Chemistry assays are new formulations that will replace the current assays you are using
today. Current on-market assays will be phased out approximately six months after the new list numbers become
available in your country. To ensure a smooth transition within your laboratory, and to support conversion studies, Abbott
is providing Data Equivalency Sheets summarizing comparative results of current to new assay performance and
Instructions for Use for each assay.
Your Abbott team of resourceful advocates looks forward to supporting you through these upcoming assay conversions.
Kind regards,
04T0220 4 x 125
Architect Iron 2 Architect Iron 06K9530 3 x 306
04T0230 4 x 310
Alinity Iron 2 04T9820 4 x 225 Alinity Iron 8P3920 10 x 230
© 2020 Abbott. All rights reserved. All trademarks referenced are trademarks of either the
Abbott group of companies or their respective owners.
ADD-124759-APAC-EN